Showing posts with label ceta. Show all posts
Showing posts with label ceta. Show all posts

Monday, October 01, 2018

The Cost of Canadian IP Capitulation in NAFTA.



(Wikimedia)

Here are a few quick initial points on the IP chapter in the new NAFTA and Canada’s capitulation to US lobby groups, their Canadian surrogates and American bluffing and bullying.

The extension of the copyright term to life + 70 was a very unfortunate, gratuitous, unnecessary and costly mistake. This could cost Canada more than  $450 million a year and most of this would be outflows to the USA.  It will make research and education more expensive and chill innovation. And, according to at least a couple of respected Canadian academics, namely Ariel Katz and Graham Reynolds, it may well be unconstitutional.

The extension of criminal penalties is alarming and dangerous. This could affect employment relationships and even reach into class rooms, especially if the Federal Court’s decision in Access Copyright v. York University is not convincingly overturned on appeal.

It is of little or no use or comfort to say that Canada can reassess this in the future. Increasing IP rights is a one-way ratchet. There is rarely if ever a legally or politically acceptable way to back down from vested rights, no matter how improvidently bestowed.

This is a significant setback to the multilateral liberal order in free trade. Canada has now become a victim by capitulating to a bluffing bully regime bent on weakening or destroying institutions such as the WTO and WIPO. I have written about how Canada was smart and managed to mostly punch well above its weight and in its own best interests and even positively influence and show leadership on the world stage involving trade and IP for 150 years. It seems that those days are sadly over.

I have no doubt that Canada’s negotiators did their homework and did their best. But there will no doubt be lots of questions about whether there was adequate consultation and transparency, whether Canada should have called the American’s bluff and waited until the mid-terms are over, why we retreated from victories in CETA and CPTPP, etc. But for now, regarding the IP chapter, all that can be said is that Canada caved and capitulated “bigly”.

HPK

PS: Here's the statement of  Canadian Generic Pharmaceutical Association (CGPA), on the pharmaceutical intellectual property aspects of the United States-Mexico-Canada Agreement (USMCA). 


Wednesday, November 08, 2017

Maybe the Canadian Copyright Bar and the Copyright Board Should Try Some PMNOC Remedies Instead of Rearranging the Deck Chairs?



(deck chairs you know where awaiting rearrangement...)

On November 3, 2017, I spoke at the University of Toronto Sixth Annual Patent Law Conference, on the “promise” issue and its treatment in parallel proceedings with very interesting timelines by a NAFTA ISDS tribunal and Supreme Court of Canada. I shall have a lot more to say about that later in a separate posting.

The conference opened with the panel discussion chaired by Chief Justice Crampton of the Federal Court about how the Court would deal with the new regime that will eliminate the troubled two track PMNOC applications and litigation proceedings regime that has existed for many years in the federal court. Even under the old system, the Court was required by law to deal with the “NOC Applications” (where in rem validity and infringement were not determined) within 24 months from start to finish including the judgment. Under the new system, as required by CETA, the proceedings will be in the form of an action with discoveries and live witnesses (in contrast to an application in which there was no oral evidence) and will also deal with in rem validity and infringement determinations. All of this must be dealt with within 24 months from beginning to end, which will include a hearing of normally two weeks maximum to take place at least three months before the end of the two-year period so as to allow the judge time to write a judgment. Here is how the Court has spelled out how this will be done. Based on the Court’s admirably transparent and useful statistics for the last several years, it is safe to assume that there will be dozens of such proceedings per year for the foreseeable future. There are about 40 active judges on the Federal Court. However, many are “supernumerary” which means that they usually carry about half of a normal case load – which can still be considerable. They each have only one clerk. There is no in-house research facility. The vast case load of the Federal Court ranges from admiralty to extradition to land claims to environmental issues and much more in terms of jurisdiction, including countless immigration files which are obviously extremely important to the individuals involved. Many cases are immensely complex both legally and factually and can involve enormous amounts of money and huge public policy issues. Most Federal Court judges manage to issue an important judgment every month and judgments are expected normally within six months after a hearing, which normally takes place within one to two years at most after the proceeding is commenced. Many proceedings are very competently and often aggressively “managed” (i.e. moved along) by Case Management judges (who are sometimes Prothonotaries with more limited powers than Judges). 

This should serve as a much-needed reality check on what is happening, or more accurately not happening, at the Copyright Board. The Copyright Board rarely holds more than two or three contested hearings a year and rarely issues more than five actual “tariffs” per year. Very few of the matters coming before the Copyright Board are ever nearly as complex factually or legally as these pharmaceutical patent cases, which also usually involve very large amounts of money.

And yet, everyone knows that for contested matters the Board typically takes more than four years even to get to a hearing and more than three years thereafter to render a decision that is almost invariably and often successfully challenged in the Federal Court of Appeal and, six times in the last five years or so, taken to the Supreme Court of Canada. These decisions are invariably retroactive for several years causing great doubt and uncertainty for all concerned, and often unexpected windfalls or liabilities as the case may be. Even the uncontested matters move at barely more than a glacial pace.

If the Federal Court, which has a very broad mandate and enormous caseload based on a vast range of subject matter, can deal with dozens of pharmaceutical patent cases each year and dispose of actions including discoveries and two-week trials from beginning to end including judgment in 24 months or less, surely it is not too much to expect similar performance results from the supposedly expert and specialized Copyright Board with its tiny fraction of the Federal Court’s caseload. However, it is clear that the only way that this will happen is with specifically mandated legally imposed deadlines as we are now seeing in the Federal Court and have seen elsewhere. All the talk about increased resources for the Copyright Board, which is not only unnecessary but potentially even very counterproductive, and the rearranging of specifics, such as they are, of the procedural steps in the Board’s Model Directive on Procedure, and other suggested tinkering, will be of no effect in the absence of legislation and/or regulations that set forth the basic procedural steps and deadlines for meeting them. Many of the submissions in the recent consultation effort involving suggestions for fixing the Copyright appear to be pulling their punches, or not even punching at all or in the right direction.

The Federal Court, the PMNOC bar and ISED are to be congratulated for dealing decisively with a very urgent, vast and complex situation that is, by any measure, much more difficult than that facing the Copyright Board.  The Copyright bar and the Copyright Board have much to learn from this example and, if they ignore it or fail to learn from it, may do so at their considerable peril. The Minister of ISED may wish to consider a process to encourage - and if necessary require - such learning and instruction.

Note that the Board has recently issued an astonishing number of notices directed toward holding hearings involving countless parties and consolidating several proposed tariffs no later than May and June of 2018 in an apparent effort to accelerate the imperceptibly glacial pace of its previous proceeding. This is notwithstanding the onslaught of judicial review resulting from the Board’s extremely belated and very likely incorrect ruling on the so-called “making available” right and the tariff itself more than 39 months after the retirement of Chairman William Vancise who presided over that already long delayed matter. Here are the key notices:

06/10/2017
Notice
Online Music Services (SOCAN: 2014-2018; Re:Sound: 2013-2018; CSI: 2014-2018; CMRRA: 2014-2018; SODRAC: 2014-2018; Artisti: 2016-2018)
06/10/2017
Notice
Internet - Audiovisual Content and User Generated Content (SOCAN: 2014-2018; CMRRA: 2016-2018; SODRAC: 2015-2018)

The first matter is very intertwined with the “making available” morass, which could have and should have been resolved many years ago by means of a simple reference to the Federal Court of Appeal. Instead, the Board allowed what should have been at the most a simple legal question to turn into an immensely complicated and unnecessary battle of international experts and then, in turn, failed to decide the legal issue quickly and separately from the rate determination. The result is five judicial review applications that cannot foreseeably be determined in time to avoid a potential train wreck of a hearing next June or, at the least, immense wasted expense on interrogatories and experts. If the Board follows through on this schedule that will result in a June 2018 hearing before the FCA has ruled (and potential SCC involvement), the resulting potential for chaos is painful to contemplate. If the parties object to this sudden rush, the Board may suggest that it is the parties to blame for the slowness of proceedings. On the other hand, parties may have their own reasons at this time for being deferential to the Board on this file. There is plenty of blame to attribute all around for the present state of affairs – and at this point, undue haste may create even more waste.

On both of the above files, there are a great many other notices that follow, which can be found here.

The Board’s apparently sudden and  frenetic activity -  especially in the face of active judicial review that could render much of this to be a waste of considerable time and resources - is doubtless going to be perceived as being a reaction to the Senate and the Government’s concern and  consultation effort concerning the Board and the S. 92 review about to begin. Whether or not the Board can get to these hearings by May and June of 2018 - or whether the many parties so accustomed to slower and more leisurely proceedings let this happen – remains to be seen. Whether the consequences of this new infusion of administrative adrenalin with lead to clarity or chaos also remains to be seen.

The obvious solution to the overall problems at the Board that can no longer be ignored is that the Government should ensure through regulations and, if necessary, legislation, that:
  • Timelines are set, as in the case of PMNOC matters, that result in tariffs being determined with reasons within a finite time. If 24 months works for pharmaceutical patents, it should also work for Copyright Board tariffs with no exceptions.
  • Copyright Board tariffs should never be retroactive – or at most only minimally so to the necessary extent, consistent with Supreme Court of Canada jurisprudence going back to 1954. See Maple Leaf Broadcasting v. Composers, Authors and Publishers Association of Canada Ltd. [1954] SCR 624 at p. 631. See also Canadian Broadcasting Corp. v. SODRAC 2003 Inc., [2015] 3 SCR 615, 2015 SCC 57 (CanLII) at paras 109-111 where I, along with Prof. Ariel Katz and Prof. David Lametti, as he then was, succeeded in getting retroactivity on to the Supreme Court’s radar screen in the modern era.

Longer term solutions, such as a change of “machinery” that might create a new tribunal perhaps merged with the Competition Tribunal, should also be considered, as I have already suggested to the Senate and in the current consultation.


HPK

Sunday, January 01, 2017

Welcome, Mr. Walt Disney, to the Canadian Public Domain

(Disney in 1946 - Wikipedia)

Today is public domain day in Canada for the works of any sole or last surviving joint author who died in 1966. Canada has a copyright term of life + 50 years.

Walt Disney, the person, died on December 15, 1966. This means that any works of which he may have been the sole or last surviving joint author are now in the public domain in Canada as of January 1, 2017. It will be interesting to see if there are such works. In Canada, there can sometimes be legal and factual complexity and uncertainty in the determination of authorship and the copyright term of films.

As anyone who knows anything about copyright law knows, it was The Walt Disney Company that pushed the US Congress and the Clinton administration to extend the American copyright term to life + 70 years in 1998 through the Copyright Term Extension Act, sometimes referred to as the Mickey Mouse Protection Act.

There are no credible policy reasons to extend the copyright term beyond that of life + plus 50 years. However, there are billions of reasons in the form of dollars for shareholders in legacy copyright-based companies, such as Disney, to do so. Not only will revenue streams be extended – but term extension sets up effective barriers or delays to entry for anyone who dares to emulate Disney’s business model that was built upon exploitation and reliance upon the then much more recent entry of works into the public domain. Here is an article in Forbes by Derek Khanna entitled 50 Disney Movies Based On The Public Domain.

Indeed, those who believe in innovation should strongly oppose term extension. There is no substantial incentive value to any living creator – and obviously no incentive value whatsoever to dead creators – involved in the theoretical possibility of windfall revenues for great-great grandchildren and even beyond. Indeed, excessively effective copyright protection can serve as a disincentive to creativity. See F.M. Scherer’s brilliant book Quarter Notes and Bank Notes: The Economics of Music Composition in the Eighteenth and Nineteenth Centuries.  He suggests that “In the case of Verdi, greater remuneration though full exploitation of the copyright system led perceptibly to a lessening of composing effort.” (p. 194). Verdi, of course, is high if not on top of the pantheon of opera composers. Copyright is not the only and arguably far from the most efficient tool to incentivize literary, dramatic, musical and artistic creativity.

Canada, China and many other countries have not followed Disney’s company’s wish to extend the copyright term to life + 70 years. I take some credit for stopping a stealth move by the Canadian Government to extend the copyright term in 2003. Here’s my “Mouse in the House” National Post op-ed that played a significant role in that resistance. Canada, to its credit, held the line on the life + 50 term in CETA – even though the EU had long since gone to life + 70 even before the Americans. However, the now apparently dead TPP (which Canada had signed) would have extended the term to life + 70 in Canada.

If NAFTA is really going to be reopened as Trump threatens, look for American pressure as focussed and amplified through the usual Canadian lobbyists to escalate the Canadian copyright term to life + 70.  Hopefully, Canada will stand its ground.  The previous Government shamefully snuck through a 20 year term extension in 2015 for sound recordings in an omnibus budget bill at the behest of lobbyists for the American recording industry. I wrote the following on November 17, 2015 based upon a recent New Zealand government study:
Assuming that the New Zealand study methodology for calculation of the cost of a 20 year copyright term extension were to be more or less applicable to Canada and that the results would be more or less proportional to the difference in GDP, here are some admittedly “back of the envelope” calculations:

The average present value of the cost of 20 year copyright for recorded music and books term extension (which included an estimate for film and television) was estimated by NZ is NZ $505 million, which is CDN $434 million, which adjusted by GDP ratio, would work out to about CDN $4.176 billion.

The average annual cost for NZ is NZ $55 million, which is $CDN 47.3, which adjusted by GDP ratio, would work out to about CDN $454 million.

Other notable creators who died in 1966 include:
  •  Lenny Bruce, comedian
  •  Alberto Giacometti, painter and sculptor
  •  Evelyn Waugh, author
  •  C.S. Forester, author
  •  Buster Keaton, actor and director
Canada welcomes them and Mr. Walt Disney himself to the public domain in Canada.


HPK

Monday, November 07, 2016

Astrazeneca, Eli Lilly, the Supreme Court of Canada, NAFTA & a Rogue Elephant - Tomorrow Promises to be an Interesting Day

(images from Wikimedia Commons)

Tomorrow will be an eventful and very interesting day – especially for Canadian IP and trade lawyers,  a wide variety of other lawyers, as well as Canadian diplomats, politicians and bureaucrats.

On Tuesday, November 8, 2016, Election Day in the USA, the Supreme Court of Canada (“SCC”) will hear a patent case between AstraZeneca Canada Inc., et al. v. Apotex Inc., et al.  This involves the issue of “whether a promised utility doctrine properly exists”, in the words of the SCC’s summary of the case, which is not “official” and “are placed on the Court file and website for information purposes only”. Here is the full SCC summary:
Intellectual property – Patents – Medicines – Utility – Validity of patent for drug used in treatment of gastric acid conditions challenged in infringement and impeachment action – Whether “promise” in patent of improved pharmacokinetic and metabolic properties for improved therapeutic profile demonstrated or soundly predicted at time patent filed – What is the correct applicable standard for patent utility in Canada? – Whether a promised utility doctrine properly exists.

The applicants, (collectively, “AstraZeneca”) owned the Canadian ‘653 patent for the compound, esomeprazole, a proton pump inhibitor used in the reduction of gastric acid, reflux esophagitis and related conditions. It was sold under the name Nexium, and was a very successful drug for AstraZeneca. The respondents (collectively, “Apotex”) applied to the Minister of Health to obtain a Notice of Compliance which would allow it to sell its generic version of the drug. In response, AstraZeneca brought a prohibition application under the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133 to prevent Apotex from entering the market until after the expiry of the ‘653 patent. In 2010, that application was dismissed and Apotex received its Notice of Compliance and commenced sales of its generic esomeprazole. AstraZeneca brought an action against Apotex for patent infringement. Apotex counter-claimed to impeach the ‘653 patent on several grounds.

It looks like this issue will now finally actually be considered on the merits by the SCC. However, there is an unusual history as to how it got here. Almost exactly two years ago, on November 3, 2014, Apotex and Sanofi settled a case scheduled to be heard by the SCC literally the next morning. The Justices were, so to speak, all dressed up, prepared and ready to go. They and the interveners may not have been too pleased. Here is what I wrote at the time:
In a very unusual development in a case that promised to be very interesting and important both domestically and internationally, Apotex has filed a notice of discontinuance literally on the day before and figuratively on the steps into the Court in its appeal against Sanofi in the Supreme Court of Canada that was to have been heard earlier today in Apotex et al v. Sanofi et al.  The notice states that “The Appellants wholly discontinues this Appeal on a without costs basis on consent.” This language suggests that some kind of settlement agreement – presumably very confidential – must have been concluded.
…
In today’s discontinued case, the “promise doctrine” and “utility” are also very much are the heart of the Eli Lilly NAFTA Chapter 11 investor/state challenge, although today’s case and the NAFTA case are not directly linked. However, whatever the Court might have ruled in today’s discontinued case might well have been of some considerable interest in the NAFTA case that we will hear much about in the future as it unfolds.

Even that was not the first time the SCC had heard about the “promise doctrine”.  In 2013, a panel of the Court led by now retired Justice Rothstein held an extraordinary rare oral hearing on whether Eli Lilly should be allowed leave to appeal on this issue. On May 16, 2013, the Court declined the leave application, as usual without reasons. Here is the webcast of the hearing.

At tomorrow’s hearing there will a rogue elephant lurking nearby and possibly even in in the room that I expect will remain almost completely silent and will likely be carefully ignored. However, it may well be on everyone’s mind – perhaps even that of the Justices. It is perfunctorily alluded to in the material.  This is the Eli Lilly NAFTA challenge, which has been brought under the ultra-controversial Investor State Dispute Settlement (“ISDS”) provisions of NAFTA. ISDS, of course, is one of the reasons, if not the main reason, for the CETA and BREXIT crises and the controversy over the TPP. Deadlines for treaty signature sharpen the mind. The timing of tomorrow’s hearing is somehow ironic – since the NAFTA and proposed TPP have become major issues in the USA election campaign, which has been otherwise largely devoid of substantial issues and mostly about personalities.

There are many things about ISDS generally and this case in particular that are very controversial. However, the most controversial aspect of this by far is the fact that Eli Lilly has refused to accept the SCC’s denial of its leave application as the end of this matter. It has, in effect, attempted to go over the head of the SCC. The SCC, after giving Eli Lilly the almost unheard of privilege of a lengthy oral leave hearing, declined to hear their appeal. For any Canadian litigant, that would have been the end of the road. Not, however, for Eli Lilly, a foreign investor, which had applied for leave to appeal on November 8, 2012 and filed its Notice of Intent Notice of Intent to Submit a Claim to Arbitration Under NAFTA Chapter Eleven on June 13, 2013, having been turned down for leave to appeal by the SCC less than a month earlier. Canadians do not get to bypass or, in effect, appeal from decisions of Canadian courts. Their only recourse is to the SCC. And when the SCC says it’s over, then it’s over. The only recourse then, which is not judicial or arbitral, and which is exceedingly rare is that Parliament may decide to change the law following a judicial decision that it finds unacceptable. Even then, Parliament is bound by Canada’s constitution, which is exceedingly difficult to change. Of course, a government can invoke the “notwithstanding clause” – but this is bordering on the “nuclear option” in today’s Canada.

Eli Lilly, at least, had exhausted its recourse in Canada in this instance. That is not the case in many other NAFTA ISDS disputes.

Only now are more and more people beginning to understand why ISDS is so controversial. It not only arguably ousts the jurisdiction of Canadian superior courts. It arguably discriminates on the basis of nationality by providing greater rights and remedies to foreigners than are provided to Canadians.  This, and much more, may get challenged by Paul Hellyer, P.C. in a recently launched lawsuit in which he is being represented by Rocco Galati, who succeeded in a controversial challenge to the appointment of the Honourable Marc Nadon to the SCC. The recent decision by the UK High Court regarding Brexit may well be cited in Canada with respect to limits on the royal prerogative and other issues.

Many experts do not believe that Eli Lilly should or will win the NAFTA challenge on the merits. It is difficult to believe that a finding of patent invalidity by one of the best judicial systems in the world with an extraordinary oral hearing for leave to appeal to Canada’s highest court could lead to the conclusion that Canada, in Eli Lilly’s words:
“Wrongfully Expropriated Claimant’s Patent Rights In Zyprexa and Strattera”

or

“Failed to Accord Fair and Equitable Treatment to Claimant’s Investments in Violation of NAFTA Article 1105”

However, Eli Lilly has paid out a lot of money to get expert reports and make arguments that suggest otherwise and Canada has chosen to defend on the merits, rather than attempting to end this case at the outset on jurisdictional grounds.  To no doubt oversimplify, the main issue is whether a ruling by the Canadian courts that a patent is invalid is an “expropriation”. That, of course, is arguably an absurd suggestion. Patents are regularly invalidated by courts everywhere. That is not “expropriation”. This is how the system works. The patent has not been seized or taken by the government without compensation.

Sometimes – and I do not for a moment suggest that this is the case here – the courts get things wrong. The wrong decision is not always corrected on appeal, for any number of reasons. A country’s highest court cannot hear every case brought to it – and rarely do any top courts engage simply in “error correction” as such.  Unless there is evidence of corruption or other serious denial of natural justice in the judicial system - which is clearly not the case here or ever likely to be the case in Canada - ISDS should never be allowed to be used to bypass or, in effect, override Canada’s judicial system. If Canada’s statute is offside with its treaty obligations, there is a state/state remedy procedure in the WTO.  However, that has not been sought in this case.

Also, more another day on why the Government of Canada did not seek at the earliest possible stage to have this case dismissed on what would seem to be arguably clear jurisdictional grounds – instead of spending about $6,000,000 that we know about in fees, disbursements and costs. However, the real and even more serious risk is that there could be a ruling by the arbitrators for damages of $500 million + costs that, even worse still, might unravel Canadian patent law and contradict our courts – including our highest court. Even if Canada wins on the merits, there is also a real risk that there could be many more of these challenges that threaten sovereignty and the rule of law - unless there is a very clear jurisdictional ruling in Canada’s favour. Litigants such as Eli Lilly, Phillip Morris and others with deep pockets have little to lose and much to gain if they can instill some regulatory chill and even buy time in appropriate cases. I may have more to say about ISDS and Canada in the future.

In the meantime, don’t take my word for what is problematic about ISDS. Here is what the Chief Justice of Australia, RS French, had to say about ISDS on July 9, 2014 – and bear in mind that sitting Chief Justices in common law countries are invariably very constrained in their comments on public policy issues:
A rule of law issue
The topic of investor-state dispute settlement has a regional significance for Australia because of the number of BITs and FTAs it has entered into or is negotiating with countries in the Asia Pacific. However, the significance of ISDS arbitral processes is global. They have general implications for national sovereignty, democratic governance and the rule of law within domestic legal systems. Their long-term consequences for national judiciaries cannot be stated with confidence. They attract vigorous and articulate proponents and detractors, but their merits and demerits are not easy to assess. Moreover, those merits and demerits may vary according to the circumstances in which ISDS is applied and the scope and limitations of particular ISDS provisions.
(emphasis added)

The possibility of diverging findings on the same issue now looms very large. We do not know when the NAFTA arbitrators will rule. While they work on their conclusion, they are each being paid at the rate of USD $3,000 per diem. One would think that, if the arbitrators were inclined to dismiss on straight jurisdictional grounds, which Canada eventually got around at the end to forcefully arguing, that they would have so ruled by now or will do so rather soon. The hearing concluded in early June of 2016. Our SCC usually rules within six months of a hearing – so one can expect a ruling from the SCC likely no later than April of 2017.

It will be a potentially huge problem if the NAFTA arbitrators and the SCC disagree on substantive patent law. It will be awkward enough if, as seems inevitable, one rules before the other. Would the NAFTA arbitrators pay any attention to the SCC, or vice versa? A disagreement on the merits would likely have profound implications for international trade, diplomacy, the rule of law and national sovereignty. However, I have probably said more than enough about all this for now….

Tomorrow’s webcast – assuming it is not delayed due to a “sealing order” should be available here.

HPK

Thursday, October 27, 2016

Hellyer et al v. Right Honourable Justin Trudeau et al T-1789-16 re CETA Challenge Statement of Claim

Here is the Statement of Claim in Hellyer et al v Justin Trudeau et al T-1789-16 launching a constitutional challenge  of the Government of Canada's jurisdiction to sign, ratify  and implement the proposed CETA. 

This is big news and the Statement of Claim is very interesting indeed. It has been brought by Paul Hellyer, P.C. et al. The lawyer is Rocco Galati, who successfully challenged the former Government's attempt to appoint the Honourable Marc Nadon to the Supreme Court of Canada.

This comes at the same time as Wallonia has apparently secured an agreement in the US to put the #ISDS provisions of #CETA to the test in the #ECJ, where approval is far from certain. 

As the Guardian reports:
One concession he won means Belgium would be able to go to the European court of justice to determine whether the new investor-state special tribunals are compatible with EU law. The four-page document also contains a guarantee that the Belgian government will assess the socio-economic and environmental impact of Ceta.
HK

PS:

Note: It appears that there is a typo throughout the Statement of Claim re the spelling of Hellyer's name, which appears incorrectly as "Helleyer". This makes it tricky to search for the docket, which can be found here. This will presumably be corrected.


Thursday, October 17, 2013

Speech From the Throne 2013 – Will We Really Get Price Parity on Consumer Goods with the USA? IP Law is a Key Issue.

Yesterday’s  Speech from the Throne (#SFT13) contained two items that will require detailed consideration of amendments or clarifications of existing Canadian intellectual property law and amendments or clarifications to the anti-counterfeiting Bill C-56 from the previous session – or whatever it is numbered if and when it is resuscitated.

#SFT13 says:
·         “Our Government will ...Take further action to end geographic price discrimination against Canadians."
·         “And our Government will take additional action to protect Canadian consumers. Canadians are tired of hidden fees. They deserve to know the real cost of paying by debit or credit card. And they should not be charged more in Canada for identical goods that sell for less in the United States.”
Achieving these goals requires dealing with some extremely complex issues that have bedevilled courts and legislatures for decades. The elephant in the room is the issue of “parallel imports” or “grey market” goods – namely perfectly legitimate and authentic products that have been legally made and put on the market outside of Canada and which can be imported into Canada at a cheaper price than that demanded by the so-called “exclusive” distributor.  These good are by no means whatsoever “counterfeit” or “pirate” in any sense.

Despite the complexity of the “parallel imports” issue in terms of copyright law, some propositions are very simple.

Truly “free” trade cannot permit the imposition of “private tariffs” in the form of IP laws that permit geographic price discrimination or market segmentation. That would allow copyright law to become an unintended “instrument of trade control”, in the words of retired Justice Fish of the Supreme Court of Canada, and a very effective and unregulated “private tariff”.

Canada has explicit provisions in its Copyright Act regime that permit and encourage just such a regime for books. The situation for goods other than books is more complicated.

In 2007, the Supreme Court of Canada in the Kraft decision allowed a victory for the importer of “parallel import” or “grey market” Toblerone chocolate bars, largely based upon arguments that I made on behalf of the Retail Council of Canada. For a number of reasons, including the complexity of the decision and the issue itself, that victory has not been fully understood, even by some those importers who might benefit from it. Here’s an analysis I did for the Law Society of Upper Canada in 2008 that’s still useful.

Here is a summary of where the law now stands:
  1. The sui generis book regime in the Copyright Act works well to keep out commercial scale importation of parallel imports and my much missed “remainder” fine art books, but is ineffective to stop personal importation by travellers and by Canadians who cross-border shop from the comfort of their own home or with their smart phone via electronic commerce in very large quantities.
  2. Trade-marks law is ineffective to stop parallel imports.
  3. In theory, copyright on elements of packaging and labelling can be used to exclude parallel imports if the copyright is assigned to a Canadian entity that is different than the foreign entity that made the packaging.
  4. However, there’s a very good chance that such an assignment will trigger one or more of the following unintended and unfortunate consequences:
  • Undesirable corporate and tax law consequences
  • “Loss of distinctiveness” resulting in invalidity of trade-mark registrations
  • Defence and Counterclaim allegations in any vigorously fought litigation relating to sham transactions, copyright misuse, abuse, and/or various Competition Act issues. (I have raised such allegations in a test case proceeding which then fizzled and never went forward).

Thus, copyright law – other than in respect of books – is essentially a toothless tiger when it comes to excluding legitimate parallel imports. But a lot of supposedly well-informed importers don’t get that, for the reasons stated above and for other reasons, which I won’t go into here.

Therefore, clarification of the law would be useful and maybe even essential. Even experienced IP lawyers have been baffled by it for decades. It is little wonder, then, that many of their clients and even the general counsel of their clients often don’t understand it. Maybe Parliament needs to make it sufficiently clear in simple terms so that even a copyright lawyer can understand it. I look forward to helping to find the appropriate language.

In the case of books, unless we want to keep an arguably anachronistic, anomalous and clearly protectionist regime that guarantees higher prices to Canadian consumers and higher profits to Canadian “exclusive distributors” but little else in terms of benefits to Canada, it is essential that the Copyright Act be amended. Otherwise, we are certain to continue have higher book prices overall in Canada than the USA, unless the current market forces of Amazon and others put Canadian exclusive distributors and some publishers out of business, which would not be a desirable result. As for the rest of Canadian copyright law, clarifying language seems necessary for the reasons stated above.

The anti-counterfeiting Bill C-56 – which may or may not get revived in the new session – has countless confusing references that deal with parallel imports.  While the intention seems benign, the result may not be. Much more scrutiny and simplification may be required to ensure consistency with the Speech from the Throne statements.

In any event, these Speech from the Throne items cannot be achieved without considerable attention to IP details.

No doubt, the lawyers and lobbyists who would like to preserve the “private tariff” of IP to prevent real free trade and to geographically segment the Canadian market for price discrimination purposes are already hard at work to thwart the Government’s intention and to recover from their failed attempt in the Kraft case to hijack copyright law for this purpose.

And last but not least, let’s hope that the #CETA and #TPP agendas don’t derail the perfectly laudable sentiments in #SFT13.

In that connection, beware of the predictable efforts from the US Government and lobbyists representing American interests who will take their frequent posture of “do as we say, not as we do”. The US Supreme Court recently clarified in the Kirtsaeng decision that copyright law cannot be used to stop the parallel importation of goods – indeed the case was about books – largely based upon a “parade of horribles” that would result had it ruled otherwise.

As I occasionally explicitly reiterate, the views expressed on this blog are solely my own.

HPK

Wednesday, August 28, 2013

Canadian Copyright and Related Issues - Suspense at Summer’s End



Here are some developments we can expect soon in Canadian copyright law:

  • York University will likely very soon file a statement of defence in the lawsuit by Access Copyright. This has already taken months longer than usual. York’s position and strategy will inevitably attract much scrutiny, since an adverse outcome for York could profoundly and negatively affect the entire Canadian educational community at all levels.
  • The Federal Court could rule at any time in the Voltage Pictures effort to compel Teksavvy to hand over the identities of thousands of its customers. Teksavvy, it will be recalled, has spent a lot of money not to take a position on this issue and to buy time for a law school clinic to get involved as an intervener. Teksavvy’s counsel spoke briefly at the end of the hearing, which took place on June 25, 2013 but Teksavvy had not previously taken any position.
  • The Copyright Board has just advised that “the Tariff of Levies to Be Collected by CPCC in 2012, 2013 and 2014 on the Sale, in Canada, of Blank Audio Recording Media is scheduled to be published in the Canada Gazette this Saturday, August 31, 2013. The links to the certified Tariffs, as well as the decision in respect of each Tariffs will be available on our web site under the heading “What’s New” on Friday, by the end of the business day.” The Board will also, at some point, rule on whether it intends to proceed with a hearing on whether there can be a levy on microSDs for the period of January 1 to November 6, 2012. The Government published a regulation on November 7, 2012 that stated that “Memory cards in microSD form factor, including microSD, microSDHC and microSDXC cards, are excluded from the definition “audio recording medium” in section 79 of the Copyright Act.”
  • The Supreme Court of Canada could at any time now deliver its judgment in the case involving Cinar and Claude Robinson, et al which will presumably focus on the question of what is a “substantial part”.

In the somewhat longer term, we know that we will see:

  • The hearing in the Federal Court of Appeal on the Warman v. Fournier case, which involves fair dealing, substantial copying, limitation periods, etc. and in which there are now some prominent interveners.
  • A ruling by the Copyright Board in Access Copyright’s quest to get a tariff on copying by provincial civil service employees.
  • A hearing next May by the SCC on the interplay between the Status of the Artist Act and the Copyright Act and whether the National Gallery must negotiate exhibition rights, etc. with respect to pre-existing art works under the aegis of the former act rather than the latter, under which the artists have apparently never even tried to get a tariff at the Board.
  • A hearing by the Federal Court of Appeal on whether Catherine Leuthold gets the $22 million or so that she believes she is owed by CBC for the few apparently inadvertently unlicensed re-uses of a few of her still photos from 9/11 that the Federal Court said was worth less than $20,000 and what the cost consequences may be to her if she does not succeed.
  • A hearing beginning February 11, 2014 by the Copyright Board of the Access Copyright proposed Post-Secondary Tariff, in which the AUCC has spent almost $2 million that we know about and withdrawn its objections, leaving its members without any representation in a hearing in which Access Copyright is seeking what it considers to be a “mandatory” tariff.
  • A hearing by the Copyright Board beginning April 29, 2014 into Access Copyright’s proposed tariff for K-12 schools, which is taking place notwithstanding that the K-12 school boards have stopped paying anything to AC under the previous tariff.

Other issues to watch in the medium term will include:

  • How will the educational community react to York’s defence of the Access Copyright litigation?
  • Will Access Copyright sue one or more K-12 school boards?
  • Whether the Government will look at growing calls to deal with certain issues involving the Copyright Board, some of which could be dealt with by regulation, rather than legislation.
  • Whether Canada gives into expected American and/or European pressure to extend the copyright term to life + 70 years, etc. and other potentially controversial US and EU IP demands in the TPP and/or CETA negotiations.
  • Whether the far reaching Bill C-56 dealing with anti-counterfeiting – but which goes far beyond what might be required even by ACTA – is reintroduced after the expected prorogation, whether changes will be made before it is re-introduced, and what will happen to it if it proceeds through the committee process.

Most of the above issues have been discussed before on this blog. Watch here for further developments.

HPK